Importantly, the PKC inhibitor GF109203X could reduce the fraction of ALDH-positive lung cancer stem cells in A549/DPP cells and reverse the Wnt5a-inhibited cell apoptosis in A549 cells. Here, WNT5A is linked to lung cancer.